Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BARD1 Antibodies

(BRCA1 Associated RING Domain 1 (BARD1))
This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. [provided by RefSeq, Jul 2008].
BARD1 antibody  (AA 101-200) BARD1 antibody  (AA 101-200) BARD1 antibody (AA 101-200) (ABIN706496)

BARD1 Reactivity: Human ELISA, FACS, IF (cc), IF (p), IHC (fro), IHC (p), WB Host: Rabbit Polyclonal unconjugated

BARD1 antibody  (Internal Region) BARD1 antibody  (Internal Region) BARD1 antibody (Internal Region) (ABIN6256958)

BARD1 Reactivity: Human ELISA, ICC, IF, WB Host: Rabbit Polyclonal unconjugated

BARD1 antibody  (AA 658-757) BARD1 antibody  (AA 658-757) BARD1 antibody (AA 658-757) (ABIN560033)

BARD1 Reactivity: Human IF, ELISA Host: Mouse Monoclonal 2A11 unconjugated

BARD1 Antibodies by Reactivity

Find BARD1 Antibodies for a variety of species such as anti-Human BARD1, anti-Mouse BARD1, anti-Rat BARD1. The species listed below are among those available. Click on a link to go to the corresponding products.

BARD1 Antibodies by Application

Find BARD1 Antibodies validated for a specific application such as WB, ELISA, FACS, IF (cc). Some of the available applications are listed below. Click on a link to go to the corresponding products.

BARD1 Antibodies by Host

Find BARD1 Antibodies with a specific Host. The Host listed below are among those available. Click on a link to go to the corresponding products.

BARD1 Antibodies by Binding Specificity

Find BARD1 Antibodies with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.

BARD1 Antibodies by Clonality

Find available monoclonal or polyclonal BARD1 Antibodies. Click on a link to go to the corresponding products.

BARD1 Antibodies by Clone

Find BARD1 Antibodies with a specific Clone. The Clone listed below are among those available. Click on a link to go to the corresponding products.

BARD1 Antibodies by Conjugate

Find BARD1 Antibodies with a specific conjugate such as Biotin, FITC, HRP. The conjugates listed below are among those available. Click on a link to go to the corresponding products.

Popular BARD1 Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application ELISA, FACS, IF (cc), IF (p), IHC (fro), IHC (p), WB
Validations
  • (1)
  • (1)
Cat. No. ABIN706496
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application ELISA, ICC, IF, WB
Validations
  • (2)
Cat. No. ABIN6256958
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application IF, ELISA
Validations
  • (2)
Cat. No. ABIN560033
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application IHC (p), ELISA
Validations
  • (2)
Cat. No. ABIN1732226
Quantity 50 μg
Datasheet Datasheet
Reactivity Human
Application ELISA, IHC, WB
Validations
  • (1)
Cat. No. ABIN7188551
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application ELISA, WB
Validations
  • (1)
Cat. No. ABIN7184419
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application ELISA, WB
Validations
  • (1)
Cat. No. ABIN7145762
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB
Validations
  • (1)
Cat. No. ABIN654621
Quantity 400 μL
Datasheet Datasheet
Reactivity Human
Application DB, IP, WB
Validations
  • (1)
Cat. No. ABIN930988
Quantity 50 μg
Datasheet Datasheet
Reactivity Mouse
Application WB
Validations
  • (1)
Cat. No. ABIN6137449
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application ELISA, WB
Validations
  • (1)
Cat. No. ABIN1534425
Quantity 100 μg
Datasheet Datasheet
Reactivity Human, Mouse, Rat
Application WB
Validations
  • (1)
Cat. No. ABIN2736345
Quantity 100 μL
Datasheet Datasheet
Reactivity Cow, Dog, Guinea Pig, Human, Mouse, Rabbit, Rat, Zebrafish (Danio rerio)
Application WB
Validations
  • (1)
Cat. No. ABIN2775649
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application EIA, WB
Validations
  • (1)
Cat. No. ABIN950603
Quantity 0.4 mL
Datasheet Datasheet
Reactivity Human
Application ELISA
Validations
Cat. No. ABIN7145765
Quantity 100 μg
Datasheet Datasheet

Latest Publications for our BARD1 Antibodies

Liu, Ao, Jia, Bai, Xu, Hu, Jiang, Chen, Wu: "FOXK2 transcription factor suppresses ER?-positive breast cancer cell growth through down-regulating the stability of ER? via mechanism involving BRCA1/BARD1." in: Scientific reports, Vol. 5, pp. 8796, (2015) (PubMed).

Tembe, Martino-Echarri, Marzec, Mok, Brodie, Mills, Lei, DeFazio, Rizos, Kettle, Boadle, Henderson: "The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function." in: Cellular signalling, Vol. 27, Issue 9, pp. 1763-71, (2015) (PubMed).

Jerjees, Alabdullah, Green, Alshareeda, Macmillan, Ellis, Rakha: "Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer." in: Breast cancer research and treatment, Vol. 145, Issue 2, pp. 317-30, (2014) (PubMed).

Alshareeda, Negm, Green, Nolan, Tighe, Albarakati, Sultana, Madhusudan, Ellis, Rakha: "SUMOylation proteins in breast cancer." in: Breast cancer research and treatment, Vol. 144, Issue 3, pp. 519-30, (2014) (PubMed).

Bosse, Diskin, Cole, Wood, Schnepp, Norris, Nguyen, Jagannathan, Laquaglia, Winter, Diamond, Hou, Attiyeh, Mosse, Pineros, Dizin, Zhang, Asgharzadeh, Seeger, Capasso, Pawel, Devoto, Hakonarson et al.: "Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. ..." in: Cancer research, Vol. 72, Issue 8, pp. 2068-78, (2012) (PubMed).

Mok, Henderson: "The in vivo dynamic organization of BRCA1-A complex proteins at DNA damage-induced nuclear foci." in: Traffic (Copenhagen, Denmark), Vol. 13, Issue 6, pp. 800-14, (2012) (PubMed).

Zhang, Pilyugin, Kuester, Leoni, Li, Casula, Zorcolo, Schneider-Stock, Atzori, Irminger-Finger: "Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome." in: British journal of cancer, Vol. 107, Issue 4, pp. 675-83, (2012) (PubMed).

Chapman, Sossick, Boulton, Jackson: "BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair." in: Journal of cell science, Vol. 125, Issue Pt 15, pp. 3529-34, (2012) (PubMed).

Wu, Sato, Koike, Nishikawa, Koizumi, Venkitaraman, Ohta: "HERC2 is an E3 ligase that targets BRCA1 for degradation." in: Cancer research, Vol. 70, Issue 15, pp. 6384-92, (2010) (PubMed).

Batchelder, Gordon-Weeks, Walker: "Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts." in: Breast cancer research and treatment, Vol. 114, Issue 1, pp. 63-9, (2009) (PubMed).

Aliases for BARD1 Antibodies

BRCA1 associated RING domain 1 (BARD1) Antibodies
BRCA1 associated RING domain 1 (bard1) Antibodies
BRCA1 associated RING domain 1 (Bard1) Antibodies
BARD1 Antibodies
ENSMUSG00000060893 Antibodies
ENSMUSG00000073653 Antibodies
LOC100147913 Antibodies
You are here:
Support